Prognostic factors for patients undergoing trans-arterial chemoembolization (TACE) for the treatment of liver metastases from neuroendocrine tumors

被引：0
|
作者：
Dong, XD [1 ]
Yin, X [1 ]
Zeh, HJ [1 ]
Bartlett, DL [1 ]
Brown, CK [1 ]
Carr, BI [1 ]
机构：
[1] Univ Pittsburgh, UPMC Liver Ctr, Pittsburgh, PA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2006年 / 13卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：65 / 65
页数：1
相关论文
共 50 条
  • [1] Trans-Arterial Embolization (TAE) is the Best Locoregional Treatment Option for Patients with Liver Metastases from Neuroendocrine Tumors
    Del Prete, M.
    Faggiano, A.
    Marotta, V
    Ramundo, V
    Marciello, F.
    Carratu, A. C.
    Colao, A.
    Fiore, F.
    [J]. NEUROENDOCRINOLOGY, 2012, 96 : 26 - 26
  • [2] Trans-arterial chemoembolization (tace) in patients with hepatocellular carcinoma
    Menon, Sreekanth
    Ramachandran, T. M.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 724 - 724
  • [3] Role of Trans-Arterial Chemoembolization (TACE) in patients with hepatocellular carcinoma
    Meshari, A. -A.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (18) : 6764 - 6771
  • [4] Prognostic factors for overall survival and safety of trans-arterial chemoembolization (TACE) with irinotecan-loaded drug-eluting beads (DEBIRI) in patients with colorectal liver metastases
    Sljivic, Maja
    Sever, Masa
    Ocvirk, Janja
    Mesti, Tanja
    Brecelj, Erik
    Popovic, Peter
    [J]. RADIOLOGY AND ONCOLOGY, 2024, 58 (02) : 214 - 220
  • [5] EFFECTIVENESS OF TRANS-ARTERIAL EMBOLISATION OF LIVER NEUROENDOCRINE TUMOUR METASTASES
    Mandair, D. S.
    Bridgestock, H.
    Shah, T.
    Mangat, K.
    Olliff, S.
    Mahon, B.
    Hussain, S.
    Johnson, P.
    Palmer, D.
    [J]. GUT, 2011, 60
  • [6] Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: Preliminary results
    Aliberti, C.
    Tilli, M.
    Benea, G.
    Fiorentini, G.
    [J]. ANTICANCER RESEARCH, 2006, 26 (5B) : 3793 - 3795
  • [7] Initial Treatment of Unresectable Neuroendocrine Tumor Liver Metastases with Trans-Arterial Chemoembolization Using Streptozotocin: A 10-Year Experience
    Dhir, M.
    Marsh, J.
    Tsung, A.
    Amesur, N. B.
    Orons, P.
    Santos, E.
    Geller, D. A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S114 - S114
  • [8] Hepatic Arterial Embolization versus Chemoembolization in Patients with Liver Metastases of Digestive Neuroendocrine Tumors
    Maire, F.
    Lombard-Bohas, C.
    O'Toole, D.
    Vullierme, M. P.
    Ruszniewski, P.
    [J]. NEUROENDOCRINOLOGY, 2011, 94 : 34 - 35
  • [9] Hepatic Arterial Embolization Versus Chemoembolization in Patients With Liver Metastases of a Digestive Neuroendocrine Tumors
    Maire, Frederique
    Lombard-Bohas, Catherine
    O'Toole, Dermot
    Vullierme, Marie-Pierre
    Rebours, Vinciane
    Pelletier, Anne-Laure
    Zappa, Magaly
    Pilleul, Frank
    Ruszniewski, Philippe B.
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S875 - S875
  • [10] Complete Response (CR) after Trans-Arterial Chemoembolization (TACE) Is a Favorable Prognostic Marker for T2 Hepatocellular Carcinoma (HCC) Patients Undergoing Liver Transplantation (LT)
    De Simone, P.
    Bargellini, I
    Lorenzoni, G.
    Tincani, G.
    Cioni, R.
    Campani, D.
    Bartolozzi, C.
    Filipponi, F.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 633 - 633
12345